Crosslinked iron oxides (CLIO): A new platform for the development of targeted MR contrast agents

Academic Radiology

Volumn 9, Issue SUPPL. 2, 2002, Pages

  Wunderbaldinger, Patrick ^a   Josephson, Lee ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; CROSS LINKING REAGENT; IRON; OXIDE; PENTETIC ACID; TRANSACTIVATOR PROTEIN;

CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CROSS LINKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYNTHESIS; X RAY POWDER DIFFRACTION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; FLUORESCENCE MICROSCOPY; MOUSE;

ANIMALS; CONTRAST MEDIA; CROSS-LINKING REAGENTS; GENE PRODUCTS, TAT; IRON; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; OXIDES; PENTETIC ACID;

EID: 0036337423     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80210-6     Document Type: Conference Paper

References (7)

1. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy
2. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells
3. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
4. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
5. Improvement of MRI probes to allow efficient detection of gene expression
6. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
7. Biodistribution of ultrasmall iron oxide particles in the rat liver